Qugen Pathlabs Private Limited
About Qugen Pathlabs Private Limited
Data last updated:
Qugen Pathlabs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 07 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U93090DL2019PTC345599.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pritpal Singh and Jasneet Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 409 – C S/F Janakpark, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.23 Cr, a growth of 100% compared to the previous year. For the same year it recorded a net profit of ₹1.31 Cr (net margin 7.2%) and EBITDA of ₹2.46 Cr (EBITDA margin 13.5%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 81% over five years.
As per MCA filings, the company has open charges of ₹27.06 Lakh on record. Court records list 7 cases involving the company, including 7 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressWz – 409 – C S/F Janakpark, New Delhi, Delhi, India – 110064
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Qugen Pathlabs Private Limited
The main business activity of Qugen Pathlabs is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Qugen Pathlabs Private Limited FY 2025 filings available
Qugen Pathlabs Private Limited reported revenue of ₹18.23 Cr (up 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Qugen Pathlabs Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 81% over five years, including 100% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Qugen Pathlabs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.46 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.31 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Qugen Pathlabs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Qugen Pathlabs are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Qugen Pathlabs Private Limited
Qugen Pathlabs Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Clumax Diagnostic and Research Centre Private Limited | ₹18.78 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Bangalore, Karnataka, India |
| Singrauli Hospital Private Limited | ₹18.64 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Singrauli, Madhya Pradesh, India |
| Aruna Scan & Diagnostics Private Limited | ₹18.49 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Sal Corporation Private Limited | ₹18.49 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Ahmedabad, Gujarat, India |
| R.S. Research and Medical Centre Private Limited | ₹18.39 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Chennai, Tamil Nadu, India |
| Qugen Pathlabs Private Limited this company | ₹18.23 Cr (FY 2025) | •••• | •••• | 100.0% | •••• | New Delhi, Delhi, India |
| JSPL Life Science Services and Holdings Private Limited | ₹18.19 Cr (FY 2020) | •••• | •••• | 220.0% | •••• | Noida, Uttar Pradesh, India |
| Medionn Diagnostics Limited | ₹18.17 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Howrah, West Bengal, India |
| Medall Scans and Labs Ranchi Private Limited | ₹18.08 Cr (FY 2024) | •••• | •••• | 57.0% | •••• | Chennai, Tamil Nadu, India |
| Telediagnosys Services Private Limited | ₹18.07 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Pune, Maharashtra, India |
| Callmedilife Healthcare Services Private Limited | ₹18.04 Cr (FY 2024) | •••• | •••• | 72.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Qugen Pathlabs by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Qugen Pathlabs Private Limited
Qugen Pathlabs Private Limited is audited by JAIN RAJEEV & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAIN RAJEEV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Qugen Pathlabs Private Limited
Qugen Pathlabs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pritpal Singh | Director | 07 Feb 2019 | 7 Years 8 Months | Current |
| Jasneet Kaur | Director | 07 Feb 2019 | 7 Years 8 Months | Current |
| Upinder Singh | Director | 07 Feb 2019 | 7 Years 8 Months | Current |
Ownership and Shareholding of Qugen Pathlabs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Qugen Pathlabs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2025 | Hdfc Bank Limited | ₹27.06 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Qugen Pathlabs Private Limited
Qugen Pathlabs Private Limited has 7 court cases on record: 7 filed by Qugen Pathlabs. 3 cases are pending and 4 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 3 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Hopeberry Diagnostics & Healthcare LLP | Pending |
| District court, West, Delhi | Court case (OMP (COMM.)) | Filed by the company against Hopeberry Diagnostics & Healthcare LLP | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Qugen Pathlabs Private Limited
Employment history and EPFO contributions of people linked to Qugen Pathlabs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Qugen Pathlabs Private Limited
Qugen Pathlabs Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jasneet Kaur was appointed as Director on 07 Feb 2019.
Credit Ratings, Litigation & Regulatory Alerts for Qugen Pathlabs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Qugen Pathlabs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Qugen Pathlabs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Qugen Pathlabs Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Qugen Pathlabs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qugen Pathlabs Private Limited
Qugen Pathlabs is an active private limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 07 February 2019 (7+ years old) and is registered under CIN U93090DL2019PTC345599.
Qugen Pathlabs reported revenue of ₹18.23 Cr for FY 2025 (up 100% YoY).
Qugen Pathlabs has 3 current directors:
- Pritpal Singh - Director
- Jasneet Kaur - Director
- Upinder Singh - Director
Qugen Pathlabs reported a net profit of ₹1.31 Cr (net margin 7.2%) and EBITDA of ₹2.46 Cr (EBITDA margin 13.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Qugen Pathlabs is 32% over three years and 81% over five years. In the latest year (FY 2025) revenue rose 100%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Qugen Pathlabs is U93090DL2019PTC345599. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qugen Pathlabs has 7 court cases on record: 7 filed by the company. 3 are pending.
Qugen Pathlabs was incorporated on 07 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Qugen Pathlabs by revenue are Clumax Diagnostic and Research Centre Private Limited, Singrauli Hospital Private Limited, Aruna Scan & Diagnostics Private Limited, Sal Corporation Private Limited, R.S. Research and Medical Centre Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Jasneet Kaur was appointed as Director on 07 Feb 2019. Pritpal Singh was appointed as Director on 07 Feb 2019. Upinder Singh was appointed as Director on 07 Feb 2019.
The registered office of Qugen Pathlabs is at Wz – 409 – C SF Janakpark, New Delhi, Delhi, India – 110064.